Assignee
RAYZEBIO INC
US·4 granted patents·7 pending applications·27 citations·filing 2022–2024
Top patents by PatentIndex Score
11 records- 0195US11541134B1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2022·Granted Jan 3, 2023·9 cites·14 claims
- 0295US11497822B1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2022·Granted Nov 15, 2022·11 cites·22 claims
- 0394US11819556B2Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2023·Granted Nov 21, 2023·4 cites·22 claims
- 0494US11707540B2Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2022·Granted Jul 25, 2023·3 cites·19 claims
- 0582US2024123098A1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2023·Application pending·0 cites
- 0674US2025057997A1Conjugates comprising covalent binders for targeting intracellular proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 0774US2024342318A1Conjugates comprising covalent binders for targeting intracellular proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 0866US2025064996A1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 0965US2025222146A1Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses ThereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1063US2024252694A1Conjugates comprising covalent binders for targeting intracellular kras g12c proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1161US2023158179A1Radiopharmaceutical conjugate compositions and uses thereofRAYZEBIO INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →